Transcranial Magnetic Stimulation (TMS) Therapy: Definition, Principal, Indications, Procedure, Efficiency and Consideration

Transcranial Magnetic Stimulation (TMS) therapy is a revolutionary, non-invasive treatment gaining popularity for its ability to help manage certain mental health and neurological conditions. 43% of U.S. adults who needed substance use or mental health care in the past year did not receive it, citing numerous barriers to access, according to the “2022 Access to Care Survey” conducted by The Harris Poll for the National Council for Mental Wellbeing.

The main indications for Transcranial Magnetic Stimulation (TMS) Therapy are treatment-resistant depression (TRD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), bipolar disorder, PTSD, and magnetic therapy for depression.

The procedure involves placing a magnetic coil on the patient’s scalp, delivering targeted electromagnetic pulses to energize brain activity. Sessions last around 30 to 40 minutes, and patients are awake and alert during treatment. The number of sessions varies, with treatment administered 5 times a week for 4 to 6 weeks. TMS is a quick, outpatient procedure with minimal preparation, and patients return to their daily activities immediately after each session.

Between 2019 and 2021, the percentage of adults receiving mental health treatment increased from 19.2% to 21.6%. In 2021, the highest treatment rate was observed in the 18–44 age group (23.2%), followed by those aged 45–64 (21.2%) and adults aged 65 and older (18.9%), as mentioned in an analysis by the Centers for Disease Control and Prevention (CDC).

The efficacy of transcranial magnetic stimulation shows a 79.4% response rate and a 60.3% remission rate on the most-rated scale, following 30 sessions of Deep TMS, as reported by Roth et al. 2024 in “Never Too Late: Safety and Efficacy of Deep TMS for Late-Life Depression.”

The main considerations before undergoing TMS therapy are safety and suitability. TMS is non-invasive and well-tolerated, but mild side effects like scalp discomfort and headaches occur. TMS is recommended for patients who have failed conventional treatments, such as medication and psychotherapy.

TMS therapy is a cost-effective option compared to long-term medication or other invasive procedures. Medicare reimburses TMS at an average rate of $206 per session, making it accessible to many patients. Private insurance plans provide coverage, further chopping out-of-pocket costs for eligible individuals. This affordability, coupled with its non-invasive nature, makes TMS a practical choice for those with treatment-resistant depression and other conditions.

What Is Transcranial Magnetic Stimulation (TMS) Therapy?

Transcranial Magnetic Stimulation (TMS) Therapy is a non-invasive procedure that uses magnetic fields to vivify nerve cells in the brain. TMS is primarily indicated for treating conditions like Treatment-Resistant Depression (TRD), Obsessive-Compulsive Disorder (OCD), and Post-Traumatic Stress Disorder (PTSD). 

TMS was first introduced in 1985 by Dr. Anthony Barker as a diagnostic tool for nerve conduction studies. TMS has been in clinical use for over 25 years, providing a well-documented safety and efficacy profile since the late 1990s.

During a TMS session, an electromagnetic coil is placed near the scalp, and magnetic pulses are delivered to the brain’s specific areas, modulating neuronal activity. TMS provides considerable relief from the symptoms of these conditions. By targeting brain regions linked to mood regulation and cognition.

The Current Procedural Terminology (CPT) code for TMS therapy is 90867 (for initial treatment planning) and 90868 (for subsequent treatments). TMS therapy received FDA approval in 2008 for the treatment of depression that is resistant to medication. TMS was later approved for OCD in 2018 and for smoking cessation in 2020. TMS is considered a legitimate and evidence-based treatment. 

TMS results are not permanent for most patients and many require maintenance sessions after the initial course of treatment to sustain benefits. Patients describe TMS as a tapping or tingling sensation on the scalp during the procedure. Some experience mild headaches or discomfort, which subside after the session. 

TMS outcomes over 10 years were analyzed in 284 patients with treatment-resistant psychiatric disorders, including major depressive disorder (MDD), obsessive-compulsive disorder, generalized anxiety disorder, and PTSD. Patients, with a mean age of 40.49±12.64, showed full response (26.1%), partial response (29.2%), and inadequate response (44.7%). MDD had the highest treatment success, while younger age and absence of PTSD were predictors of better outcomes, as detailed in “Ten years’ data of Transcranial Magnetic Stimulation (TMS): A naturalistic, observational study outcome in clinical practice” by Bolu et al. 2021.

TMS therapy is administered by psychiatrists or trained medical professionals under a psychiatrist’s supervision. TMS therapy cannot be performed at home due to the need for specialized equipment and medical oversight.

TMS therapy encompasses several key components that work together to achieve its therapeutic effects such as the electromagnetic coil being the principal tool, delivering focused magnetic pulses to targeted areas of the brain. The pulse generator controls the frequency and intensity of these pulses, ensuring they are delivered at optimal levels for therapeutic efficacy. A targeting mechanism is deployed to precisely direct the pulses to specific brain areas, such as the dorsolateral prefrontal cortex, which is for mood regulation.

The main difference between traditional TMS and Deep TMS (dTMS) lies in the technology used to deliver the magnetic pulses. Traditional TMS employs a figure-8 coil, which targets more superficial regions of the brain. In contrast, Deep TMS utilizes an H-coil, which is designed to reach deeper brain structures, offering more comprehensive stimulation for conditions that require targeting of deeper brain areas.

TMS Therapy was FDA-approved for treating depression in 2008 and is recognized as a legitimate and effective medical procedure. TMS has gained widespread acceptance in the mental health community as a treatment option for patients who do not respond to antidepressant medications. While it is commonly used for depression, it is also FDA-approved for OCD and has been studied for other conditions, such as bipolar disorder and chronic pain.

What Are the Different Types of Transcranial Magnetic Stimulation (TMS) Therapy?

The different types of Transcranial Magnetic Stimulation (TMS) Therapy are Repetitive Transcranial Magnetic Stimulation (rTMS), Deep Transcranial Magnetic Stimulation (dTMS), Theta Burst Stimulation (TBS), and Navigated TMS (nTMS). Each type of TMS therapy is tailored to specific needs and conditions, offering a versatile approach to non-invasive brain stimulation.

A study analyzed TMS and usual care (UC) outcomes for major depressive disorder (MDD) in 1,011 patients with Patient Health Questionnaire-9 (PHQ-9) scores ≥10. Only 9% (89) received TMS, with higher baseline PHQ-9 scores (17.9 vs. 15.5) and more failed medications (≥4 vs. 3.1). Over six months, PHQ-9 decreased by 5.7 points (standard deviation [SD] = 6.7) in TMS patients and 4.2 points (SD = 6.4) in UC.

For patients failing four or more antidepressants, reductions were 5.8 points (TMS) vs. 3.2 points (UC). Despite major clinical benefits, TMS adoption remains low,  highlighting the need to address barriers to its wider adoption as detailed in “Utilization and Outcomes of Transcranial Magnetic Stimulation and Usual Care for MDD in a Large Group Psychiatric Practice” by Bastiaens et al. 2024.

The different types of TMS therapy are given below:

• Repetitive Transcranial Magnetic Stimulation (rTMS): rTMS delivers repeated magnetic pulses to the brain, targeting the prefrontal cortex. These pulses modulate neural activity to boost mood and cut symptoms of treatment-resistant depression and obsessive-compulsive disorder (OCD). rTMS is used in daily sessions over several weeks.
• Deep Transcranial Magnetic Stimulation (dTMS): dTMS uses an H-coil to penetrate deeper brain structures compared to traditional TMS. dTMS is particularly effective for treating major depressive disorder (MDD) and bipolar disorder, furnishing broader stimulation to neural networks executing mood regulation.
• Theta Burst Stimulation (TBS): TBS is a faster form of TMS that delivers high-frequency pulses in short bursts. TBS achieves similar results to rTMS in a fraction of the time, completed in just a few minutes per session. TBS is used for conditions like depression and anxiety.
• Navigated TMS (nTMS): nTMS incorporates neuroimaging to target specific brain regions precisely. nTMS is for therapeutic purposes and pre-surgical mapping, ensuring precision in stimulating or avoiding critical brain areas.

How Does Transcranial Magnetic Stimulation (TMS) Therapy Work?

Transcranial Magnetic Stimulation (TMS) Therapy works by using magnetic fields to energize specific areas of the brain, modulating neural activity and ameliorating symptoms of mental health conditions. A magnetic coil is placed against the scalp, delivering repetitive pulses that penetrate the skull to reach the brain’s dorsolateral prefrontal cortex—a region sensitive for mood regulation.

The therapy operates through electromagnetic induction, where magnetic pulses generate small electrical currents in targeted neurons. These currents increase or decrease the excitability of neural circuits depending on the frequency of stimulation. For example, high-frequency stimulation (5–20 Hz) enhances neural activity, while low-frequency stimulation (≤1 Hz) suppresses overactivity.

The treatment parameters (pulse frequency, intensity, and session duration) are carefully tweaked to maximize therapeutic effects. A standard course involves 30–36 sessions, delivered over 4–6 weeks, with each session lasting about 20–40 minutes. 

Therapeutic effects of TMS are enhanced connectivity in neural networks, minimized symptoms of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), and improved emotional regulation. Its non-invasive nature and ability to precisely target dysfunctional brain regions make TMS a promising option for individuals unresponsive to traditional treatments.

A high re-response rate of 78% was observed for patients undergoing TMS again if needed, as Perera et al. 2016 cited in “The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.”

What Are the Indications for Transcranial Magnetic Stimulation (TMS) Therapy?

The indications for Transcranial Magnetic Stimulation (TMS) Therapy are treatment-resistant depression (TRD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), bipolar disorder, PTSD, and magnetic therapy for depression. Each condition benefits from the precise targeting and modulation of neural activity achieved through TMS treatment, making it a versatile solution for various psychiatric disorders.

Common indications for TMS are given below:

Mental Health Conditions

TMS is widely used to address various mental health challenges such as treatment-resistant depression, major depressive disorder (MDD), and obsessive-compulsive disorder (OCD), and PTSD. These conditions benefit from the modulation of brain activity in the prefrontal cortex, augmenting emotional regulation and cutting symptoms.

These disorders are linked to dysregulated brain activity, particularly in the prefrontal cortex, which TMS targets to improve emotional regulation and symptom management.

For treatment-resistant depression, TMS achieves a 50-60% response rate, with one-third experiencing full remission as informed by Harvard Health Publishing (2020). In MDD, TMS trims the severity and persistence of depressive episodes. For OCD, TMS minimizes intrusive thoughts and compulsions by regulating hyperactive brain regions. In PTSD, TMS alleviates symptoms like hyperarousal and intrusive memories by modulating the neural circuits associated with fear and emotional regulation.

Addiction Disorders

TMS shows promise in treating addiction by targeting neural pathways associated with cravings and reward mechanisms, improving the likelihood of recovery.

A systematic review of 94 studies evaluated neuromodulation (NM) therapies—repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS)—for substance use disorders (SUDs) like alcohol, tobacco, and opioids. rTMS showed medium to large effect sizes (Hedge’s g > 0.5 or over 70%) for bringing down substance use and craving, particularly when targeting the left dorsolateral prefrontal cortex (DLPFC) with multiple sessions.

tDCS yielded medium effects but with higher variability, with right anodal DLPFC stimulation being the most effective. DBS studies, though limited and uncontrolled, showed promise. Future research must explore NM’s neural mechanisms, longer treatments, and biochemical outcome validation, as outlined in” “A Systematic Review and Meta-analysis of Neuromodulation Therapies for Substance Use Disorders” by Mehta et al. 2024.

Neurological Conditions

TMS is effective for conditions like migraines and neuropathic pain, utilizing non-invasive brain stimulation to reduce pain perception and improve quality of life.

Transcranial magnetic stimulation (TMS) technology has greatly evolved, with advancements in signal motors, coils, placement devices, and treatment scheduling. A review spanning research from 1985 to 2023 analyzed over 500 studies across 16 medical conditions, examining TMS’s imposition on seizure management in individuals with and without epilepsy, alongside its broader applications.

While TMS shows promise, more digging is needed to refine protocols and establish definitive, non-experimental outcomes for its use in psychiatric and neurological disorders, as established by Afifi S. 2024 in “A New Era of Current and Future Treatment Applications of Transcranial Magnetic Stimulation.”

Failed Conventional Therapy

TMS is a valuable option for individuals who have not achieved results with medications or psychotherapy, offering magnetic therapy for depression and other conditions as a secondary treatment pathway.

Approximately 50% to 60% of individuals with depression unresponsive to medications achieve meaningful improvement with Transcranial Magnetic Stimulation (TMS) Therapy and about one-third experience full remission. While results are not permanent, most feel better for over a year on average. Some opt for additional treatment if symptoms return. For non-responders, electroconvulsive therapy (ECT) remains a viable option, as advanced by Harvard Medical School’s (2020) Harvard Health Publishing in the publication “Transcranial Magnetic Stimulation (TMS): Hope for Stubborn Depression.”

What Is the Procedure for Transcranial Magnetic Stimulation (TMS) Therapy?

The procedure for Transcranial Magnetic Stimulation (TMS) Therapy follows 7 main steps:

1. Initial Consultation and Evaluation
2. Treatment Planning
3. Preparation for Session
4. Positioning and Application of the Magnetic Coil
5. Stimulation Sessions
6. Post-Session Monitoring
7. Follow-up and Ongoing Treatment

Step 1: Initial Consultation and Evaluation

This step involves a detailed assessment of the patient’s medical history, mental health status, and suitability for TMS Treatment. Physicians evaluate previous treatments and use diagnostic tools, such as the Hamilton Depression Rating Scale (HDRS), to measure symptom severity. It is important because it makes certain TMS is tailored to the individual, enhancing the likelihood of success.  This process ensures TMS is the right fit for the individual and establishes a baseline for future comparisons.

Step 2: Treatment Planning

During this phase, clinicians determine stimulation parameters, covering the frequency, intensity, and duration of sessions. Personalized plans are created to target specific brain regions, such as the dorsolateral prefrontal cortex, ensuring optimal therapeutic effects. Individualized planning maximizes therapeutic benefits and minimizes risks.

Step 3: Preparation for Session

The patient is seated comfortably, and safety checks are conducted. Any metallic objects are removed to prevent interference with the magnetic coil to make for a safe and effective session. This step is vital because proper preparation guarantees patient safety and prevents complications during treatment.

Step 4: Positioning and Application of the Magnetic Coil

The magnetic coil is positioned over the targeted brain area, the prefrontal cortex. Accurate placement enlivens the intended neural pathways and achieves therapeutic benefits. Precise positioning activates neural pathways critical for therapeutic success.

Step 5: Stimulation Sessions

Magnetic pulses are delivered in short bursts to invigorate neuronal activity. Each session lasts 20–40 minutes and is repeated five days a week for 4–6 weeks. Repeated stimulation fosters neural plasticity, a key factor in symptom improvement. 

Stimulation intensity is measured as a percentage of the Rest Motor Threshold (RMT), defined as the minimum intensity needed to produce an electromyographic (EMG) response—or motor-evoked potential (MEP)—of at least 50 μV in a resting hand muscle, with a 50% likelihood. RMT is assessed by observing clinical motor responses, such as finger movements, instead of recording MEP, as highlighted by Rossini et al. 1994 in “Non-Invasive Electrical and Magnetic Stimulation of the Brain, Spinal Cord, and Roots: Basic Principles and Procedures for Routine Clinical Application. Report of an IFCN Committee.”

Step 6: Post-Session Monitoring

After each session, the patient is observed for any immediate side effects, such as mild headaches or scalp discomfort. This monitoring ensures patient safety and tracks any changes in response. Clinicians oversee the observation period, addressing any concerns promptly. Real-time tracking of patient feedback and physical responses helps adjust future sessions for optimal results.

Step 7: Follow-Up and Ongoing Treatment

Patients attend follow-up appointments to review progress and determine the need for maintenance sessions. Long-term outcomes are tracked to assess the sustained impact of non-invasive brain stimulation. Patients, therapists, and psychiatrists collaborate in these reviews. Data from follow-ups guide adjustments to the treatment plan, fostering continuous improvement and sustained relief. Monitoring long-term effects verifies the therapy’s success and supports relapse prevention.

What Are the Side Effects of Transcranial Magnetic Stimulation (TMS) Therapy?

The side effects of TMS are mild discomfort or pain, scalp irritation, headaches, mood swings, seizures, and dizziness or lightheadedness. These side effects are mild and ephemeral, with most patients encountering symptom relief as treatment progresses. The overall prevalence of adverse effects (AEs) of transcranial magnetic stimulation (TMS) among individuals with autism spectrum disorder (ASD) was 25%, as concluded by Huashuang et al. 2022a in “Prevalence of Adverse Effects Associated With Transcranial Magnetic Stimulation for Autism Spectrum Disorder.” The common and rare side effects of Transcranial Magnetic Stimulation (TMS) Therapy include:

Common Side-Effects of Transcranial Magnetic Stimulation (TMS) Therapy

The common side effects of Transcranial Magnetic Stimulation (TMS) Therapy are scalp discomfort, headaches, dizziness, and tingling of facial matches. They are mild and transient, occurring primarily during or shortly after treatment. These side effects are often a natural response to the magnetic pulses and resolve within a short time. While the severity is low, they provoke temporary discomfort or inconvenience.

• Mild discomfort or pain: Pain occurs at the site of magnetic stimulation on the scalp, especially during the initial sessions, happening 6% of the time. The discomfort is short-lived and arises from the magnetic pulses delivered by the TMS treatment coil, which elicit temporary sensitivity in the area being stimulated. The discomfort rate is 15% of the cases (Huashuang et al. 2022b).
• Headaches: Headaches after treatment sessions are one of the most reported side effects, being moderate in intensity and being done within hours. Around 10% of patients report headaches after the first few TMS treatments (2022c).
• Scalp discomfort or soreness: Due to the positioning of the TMS treatment coil on the scalp, this side effect is localized pain or sensitivity during and shortly after the session. These sensations subside shortly after the session ends, with an 8% incidence rate (2022d). 
• Dizziness or lightheadedness: Some patients experience a feeling of dizziness, which subsides soon after the session concludes. These sensations subside shortly after the session ends, with an 8% incidence rate (2022e).
• Tingling or twitching of facial muscles: This happens when the stimulation parameters affect motor regions of the brain near the facial muscles, leading to mild, temporary involuntary muscle movements.

Rare Side-Effects of Transcranial Magnetic Stimulation (TMS) Therapy

The rare side effects of Transcranial Magnetic Stimulation (TMS) Therapy are seizures, hearing difficulties, mania, and cognitive issues that are more serious but infrequent. These side effects are more severe and require medical attention. While uncommon, they accentuate the importance of careful monitoring during treatment.

• Seizures: One of the most serious but extremely rare side effects of TMS treatment. Seizures are in less than 1 in 1,000 patients, in individuals with a history of neurological conditions or those at higher risk. Repetitive transcranial magnetic stimulation (rTMS) has a low overall seizure risk, with a rate of 0.31 per 10,000 sessions and 0.71 per 1,000 patients based on 18 seizures reported across 586,656 sessions and 25,526 patients, as deduced in the study “Seizure Risk With Repetitive TMS: Survey Results From Over a Half-Million Treatment Sessions” by Taylor et al. 2021.
• Hearing issues: Although rare, some patients experience non-permanent hearing changes due to the loud sounds produced by the TMS machine. Patients are furnished with ear protection during sessions to mitigate this risk.
• Mania in individuals with bipolar disorder: Rare instances of induced mania have been observed in patients with bipolar disorder, especially those with undiagnosed or untreated manic tendencies.
• Cognitive disturbances: Some patients report short-term memory lapses or concentration difficulties after TMS sessions, although these effects are forbearing and sorted out with time.

What Are the Side-effects of Transcranial Magnetic Stimulation (TMS) Therapy in the Elderly?

The side effects of Transcranial Magnetic Stimulation (TMS) in the elderly are varied, including headaches, during or after the session and settle after treatment. Scalp discomfort at the site of the magnetic coil is reported as a temporary side effect. Dizziness presents during or shortly after the procedure, though it is uncommon. Tingling or muscle twitching in the facial muscles is possible because of stimulation near the motor cortex.

Although rare, psychiatric events such as elevated suicidal ideation or agitation have been reported. The most serious side effect, seizures, is very rare but poses a risk in the elderly, specially those with a history of seizures or epilepsy. Despite these potential side effects, the majority are short-term and straightened out shortly after treatment, with long-term risks being minimal.

A systematic review of repetitive transcranial magnetic stimulation (rTMS) in older adults with late-life depression (LLD) revealed that adverse events (AEs) occurred in 12.4% of cases, with serious AEs reported in 1.5%. The most common AEs were headaches (6.9%) and discomfort at the stimulation site (2.7%). Serious AEs included psychiatric hospitalization, posterior vitreous detachment, retinal tear, and heightened suicidal ideation.

rTMS was thought safe for older adults with LLD, although more research with larger samples is needed to optimize treatment and tolerance, as concluded in “Adverse Events of Repetitive Transcranial Magnetic Stimulation in Older Adults with Depression: A Systematic Review of the Literature” by Over Vliet al. 2020.

What Are the Effects of Transcranial Magnetic Stimulation (TMS) Therapy on Pregnancy?

The effects of Transcranial Magnetic Stimulation (TMS) Therapy on pregnancy are not fully understood due to a lack of extensive research. TMS involves magnetic fields, and while there is no major evidence indicating harm, limited investigations exist on its act during pregnancy. 

The only effect observed was a headache, which was reported as a temporary side effect in a case series in Brain Stimulation evaluated rTMS for treating major depression during pregnancy. The study showed that rTMS was safe, with only one adverse event (headache) in a patient after 29 sessions. All participants had a ≥50% reduction in PHQ-9 scores and four achieved remission. These results support rTMS as an effective treatment with fewer side effects than ECT, as emphasized by Yee et al. 2022 in “A Case Series of Repetitive Transcranial Magnetic Stimulation in the Treatment of Major Depression During Pregnancy.’

There are no reports of birth defects or complications directly related to TMS exposure, but concerns remain regarding its safety, particularly in the early stages of pregnancy. 

As a result, TMS therapy is not recommended during pregnancy unless necessary, especially in the first trimester. Most healthcare providers advise caution, preferring alternative treatments until continued studies better establish their safety.

Can You Drive After Transcranial Magnetic Stimulation (TMS) Therapy?

Yes, you can drive after Transcranial Magnetic Stimulation (TMS) Therapy. Most individuals experience only non-heavy side effects, such as headache or scalp discomfort, which do not impair the ability to drive. TMS is a non-invasive procedure, and the effects are short-lived, making it safe for patients to resume normal activities, including driving, immediately after each session. If you experience more side effects like dizziness or lightheadedness, it is advisable to avoid driving until those symptoms come down.

How to Choose the Right Transcranial Magnetic Stimulation (TMS) Therapist Near Me in New Jersey?

To choose the right TMS therapist near me in New Jersey, consider the therapist’s qualifications and experience, ensuring they are certified in non-invasive brain stimulation techniques and have specialized training in TMS treatment. Select a therapist with credentials in treating treatment-resistant depression and other mental health conditions that TMS addresses.

The facility accreditation must be up-to-date, confirming that it meets the necessary health and safety standards. Consider the insurance coverage and cost of TMS therapy, as coverage is variegated depending on your provider and the type of treatment required. Lastly, check patient reviews and testimonials to gauge others’ experiences and outcomes with the therapist and the treatment process. Patient satisfaction serves as valuable insight into the quality of care provided.

When searching for the right TMS therapist in New Jersey, it’s important to know their expertise in administering repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder (MDD). The effectiveness and safety of rTMS have been well-documented, with consensus recommendations developed by experts. This expert-backed framework aids you in assessing a provider’s qualifications and that they adhere to best practices in delivering rTMS treatment.

Repetitive transcranial magnetic stimulation (rTMS) has been supported by multiple randomized controlled trials and published literature as a safe and effective antidepressant therapy for major depressive disorder (MDD). The consensus recommendations, developed by 17 experts from the National Network of Depression Centers and the American Psychiatric Association, are predicated on a review of 118 publications and provide comprehensive guidelines for the safe and effective clinical application of rTMS in treating MDD as elaborated by McClintock et al. 2018 in “Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.”

Is Transcranial Magnetic Stimulation (TMS) Therapy Efficient?

Yes, Transcranial Magnetic Stimulation (TMS) Therapy is efficient for many patients, especially those with treatment-resistant depression and other mental health conditions. The success rate of TMS therapy is high, with approximately 50-60% of patients experiencing a clinically meaningful response, and 30% achieving full remission, as seen in Roth et al. 2024b.

Factors that affect its efficiency are treatment speed, which extends 5-6 weeks of daily sessions (about 30-36 sessions) with each session lasting approximately 20-40 minutes. The treatment is safe, with side effects such as headaches or scalp discomfort being common but not harmful and not for long. TMS therapy is considered a non-invasive and low-risk treatment option.

Cost is a substantial factor in its accessibility, with prices ranging from $6,000 to $12,000 for a full course, depending on the clinic and insurance coverage. Accessibility differs by location, with availability restricted to major medical centers or clinics, although it’s becoming more widespread. Despite this, TMS remains a viable and effective treatment for many individuals who do not respond to traditional therapies.

The four largest U.S. private-payer health plans cover over 50% of 165 million enrollees, while Medicare insures 45 million seniors. Medicare reimburses rTMS at $206 per session, below the $230 threshold for cost-effectiveness compared to drug therapy, making it a viable option for treatment-resistant patients, as explained by Voigt et al. 2017 in “Cost Effectiveness Analysis Comparing Repetitive Transcranial Magnetic Stimulation to Antidepressant Medications After a First Treatment Failure for Major Depressive Disorder in Newly Diagnosed Patients – A Lifetime Analysis.”

What Considerations Should Be Made Before Undergoing Transcranial Magnetic Stimulation (TMS) Therapy?

The considerations that should be made before undergoing TMS therapy are current medications, medical history, mental health evaluation, potential side effects, insurance cost, contraindications, and treatment goals.

The main considerations to make before undergoing Transcranial Magnetic Stimulation (TMS) therapy are given below:

• Medical History: Review the patient’s medical history to assess any pre-existing conditions that affect the treatment’s success. For example, individuals with a history of seizures are not eligible for TMS due to the risk of seizure induction.
• Current Medications: Medications taken by the patient influence the effectiveness of TMS. Some medications need to be adjusted or temporarily discontinued before treatment to curb interactions or negative feedback.
• Mental Health Evaluation: A thorough mental health evaluation is conducted to ensure TMS is appropriate for the patient’s specific condition, such as Treatment-Resistant Depression or Obsessive-Compulsive Disorder (OCD), as the therapy is deployed for patients who have not responded to other treatments.
• Contraindications: Identify any contraindications to TMS therapy, such as the presence of metal implants or a history of neurological conditions like epilepsy, which interfere with the procedure.
• Insurance Coverage: Since TMS is costly, checking for insurance coverage and verifying if the procedure is reimbursed is a key consideration, especially since not all insurance providers cover TMS for specific conditions or stages of treatment.
• Treatment Goals: Patients must have clear treatment goals to monitor the effectiveness of TMS. Whether the goal is curtailing depressive symptoms or managing OCD, understanding the expected outcomes guides the therapy’s success and sets realistic expectations.
• Potential Side Effects: Being informed of the probable side effects of TMS, such as headaches or scalp discomfort, is vital for prepping the patient for the treatment process and tackling any discomfort during sessions.

Should I Choose Transcranial Magnetic Stimulation (TMS) or Psychotherapy Therapy?

You should choose TMS therapy if you have treatment-resistant depression, Obsessive-Compulsive Disorder (OCD), or other mental health conditions that have not responded to traditional treatments like medications. TMS is a non-invasive treatment that works by stimulating specific areas of the brain with magnetic pulses. It is effective for individuals who have not benefited from medications, showing that 50% to 60% of patients with depression who failed to respond to medications experience a clinically meaningful response with TMS (Harvard Health Publishing, 2020b).

You should choose psychotherapy if you’re looking for a comprehensive approach to improving emotional well-being and have a preference for talking therapies. Cognitive Behavioral Therapy (CBT), for example, is recommended for people who are open to discussing their issues in a structured setting. Psychotherapy is efficacious for handling underlying thoughts, behaviors, and emotional challenges, and is long-term.

Most studies focus on the role of Transcranial Magnetic Stimulation (TMS) as an adjunct to antidepressant therapy. There is little research on its role as an augmenting modality for psychotherapy in patients with treatment-resistant depression. A recent study conducted in a naturalistic setting examined the combined efficacy of repetitive TMS (rTMS) and psychotherapy in managing depression.

The study comprised 196 patients diagnosed with major depressive disorder, with over 97% exhibiting treatment resistance. Results showed a 66% response rate and a 56% remission rate following the combined therapy. These findings suggest that TMS productively intensifies psychotherapy in treatment-resistant depression, offering considerable remission potential, as analyzed by Somani A. and Kar S.  2019 in “Efficacy of Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression: The Evidence Thus Far.” 

What Is the Difference Between Transcranial Magnetic Stimulation (TMS) and Deep Brain Stimulation?

The primary difference between Transcranial Magnetic Stimulation (TMS) and Deep Brain Stimulation (DBS) lies in their method of brain stimulation. TMS is a non-invasive procedure that uses magnetic fields to quicken specific areas of the brain without the need for surgery. In contrast, DBS involves the surgical implantation of electrodes into the brain, which delivers electrical impulses to specific brain regions.

TMS is used for treating conditions like depression, OCD, and other mental health disorders, showing that approximately 50% to 60% of individuals with treatment-resistant depression benefit from it as published by Harvard Health Publishing 2020 in “Transcranial Magnetic Stimulation (TMS): Hope for Stubborn Depression.”. DBS is considered for more severe neurological disorders, such as Parkinson’s disease or essential tremors, and is functional when other treatments are ineffective.

What Is the Difference Between Transcranial Magnetic Stimulation (TMS) and Magnetic Resonance Therapy?

The primary difference between TMS and magnetic resonance therapy lies in their application and purpose. TMS uses targeted magnetic pulses to excite specific areas of the brain, to treat mood disorders like depression and OCD. In contrast, magnetic resonance therapy refers to the use of magnetic resonance imaging (MRI) to visualize the brain and, in some cases, for therapy in diagnosing or monitoring conditions rather than treating them directly. TMS directly points at brain regions to alter brain activity, whereas MRI is a diagnostic tool.

A randomized, double-blind trial published in Trials appraises functional magnetic resonance imaging-guided repetitive transcranial magnetic stimulation (fMRI-rTMS) for depression with emotional blunting. Eighty patients will undergo 15 daily sessions, with 40 receiving fMRI-rTMS targeting the right medial prefrontal cortex (mPFC) and amygdala, and 40 receiving sham stimulation.

Primary outcomes encompass the Oxford Depression Questionnaire (ODQ) score changes, with secondary outcomes assessing clinical scales and brain imaging differences. Results aim to clarify fMRI-rTMS efficacy and mechanisms  as put forward by Zhang et al. 2024 in “Efficacy of Functional Magnetic Resonance Imaging-Guided Personalized Repetitive Transcranial Magnetic Stimulation in Depressive Patients with Emotional Blunting.” 

What Is the Difference Between Transcranial Magnetic Stimulation (TMS) and Occupational Therapy?

The difference between TMS and occupational therapy lies in their approaches and purposes. TMS is a neurological treatment that uses magnetic pulses to spur the brain to treat conditions like depression, OCD, and anxiety. Occupational therapy focuses on supporting individuals to perform daily tasks and amplifies functioning in daily life. While TMS targets the brain to change neural activity, occupational therapy is concerned with physical and psychological techniques to bolster motor skills, coordination, and cognitive abilities in daily tasks.

What Is the Difference Between Transcranial Magnetic Stimulation (TMS) and Constraint-Induced Movement Therapy?

The difference between TMS and Constraint-Induced Movement Therapy (CIMT) is based on their treatment focus. TMS uses magnetic pulses to dynamize areas of the brain to treat mood disorders or neurological conditions. CIMT is a rehabilitation therapy aimed at boosting motor function, particularly after a stroke or brain injury, by constraining the unaffected limb and forcing the patient to use the impaired limb. While TMS targets the brain to modify activity, CIMT narrows down on physical rehabilitation through behavioral methods.

What Is the Difference Between Transcranial Magnetic Stimulation (TMS) and Electroconvulsive Therapy?

The primary difference between TMS and Electroconvulsive Therapy (ECT) is their invasiveness and side effects. TMS is a non-invasive treatment that uses magnetic pulses to move brain regions involved in mood regulation, with fewer side effects like memory loss. ECT is an invasive procedure that induces a controlled seizure in the brain through electrical impulses used for severe depression when other treatments fail. TMS has a lower risk profile and does not require anesthesia, whereas ECT carries risks such as memory impairment and necessitates general anesthesia for each session.

A meta-analysis comparing electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder (MDD) using data from 25 trials (1,288 participants) was conducted. ECT was the most efficacious (65% probability of being most effective), but least tolerated (14%). R-rTMS was the best tolerated (52%), followed by B-rTMS (17%) and L-rTMS (16%). B-rTMS balanced efficacy and acceptability best. No pertinent incoherence was deduced in the comparisons as described by Chen et al. 2017 in “Comparative Efficacy and Acceptability of Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation for Major Depression.”

What Is the Difference Between Transcranial Magnetic Stimulation (TMS) and Shock Therapy?

The difference between TMS and shock therapy is that, unlike shock therapy, TMS is a non-invasive procedure that uses magnetic pulses to galvanize specific brain areas and shock therapy requires anesthesia and induces a seizure, TMS does not involve sedation and does not carry the same risks related to memory loss or cognitive function.

Can Transcranial Magnetic Stimulation (TMS) Treat Addictions?

Yes, Transcranial Magnetic Stimulation (TMS) can treat addictions, such as substance use disorders. TMS modulates brain circuits associated with cravings and impulse control. In alcohol-dependent participants, 6 out of 9 studies (66.67%) suggested reductions in alcohol craving and/or consumption after active rTMS treatment. Effect sizes (Cohen’s d) for rTMS on alcohol oscillated from −0.07 to 2.99, as advanced by Coles et al. 2018 in “A Review of Brain Stimulation Methods to Treat Substance Use Disorders.”

Can Transcranial Magnetic Stimulation (TMS) Treat Bipolar Disorder?

Yes, TMS therapy can treat bipolar disorder by managing depressive episodes, especially when conventional treatments have failed. TMS conveyed a 77% response rate and 41% remission rate in patients with bipolar depression, with BD1 (Bipolar Disorder Type I) patients more likely to respond or remit. 10% of participants discontinued due to concerns about activation, and no manic episodes ensued. These results were from a retrospective analysis by Goldwaser et al. 2020 in “A Retrospective Analysis of Bipolar Depression Treated with Transcranial Magnetic Stimulation.” 

Can Transcranial Magnetic Stimulation (TMS) Treat PTSD?

Yes, TMS therapy can treat Post-Traumatic Stress Disorder (PTSD) by targeting brain regions activated in fear processing and memory retrieval. The treatment is useful for patients unresponsive to medication or psychotherapy. 

5 Hz transcranial magnetic stimulation (TMS) exhibited superior symptom improvement for PTSD (d = 1.81 or 64.3%) and MDD (d = 1.51 or 60.2%) relative to intermittent theta burst stimulation (iTBS), which had decreased effect sizes for PTSD (d = 0.63 or 38.7%) and MDD (d = 0.88 or 46.8%). Both treatments were safe and diminished symptoms, but 5 Hz TMS demonstrated more magnified advancements.

These findings imply that while iTBS offers logistical advantages, 5 Hz TMS is more effective, warranting further prospective and controlled studies as recounted by Philip et al. 2022 in “Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder and Major Depression: Comparing Commonly Used Clinical Protocols.”

Can Transcranial Magnetic Stimulation (TMS) Treat Eating Disorders?

Yes, TMS can treat eating disorders by helping to alleviate symptoms of eating disorders, especially binge eating and bulimia. TMS cuts food cravings and modifies brain activity related to reward processing. Repetitive transcranial magnetic stimulation (rTMS) has been reviewed as a treatment for anorexia nervosa, specifically focusing on neural circuit manipulation. Out of 33 studies identified, 16 primary studies were eligible, investigating the effects of rTMS on regions such as the dorsolateral prefrontal cortex, dorsomedial prefrontal cortex, and insula.

The findings indicated that rTMS is safe and well tolerated for patients with anorexia nervosa, although large randomized controlled trials comparing real versus sham rTMS across various brain regions are needed for further conclusions, as spotlighted by Kim et al. 2023 in “Repetitive Transcranial Magnetic Stimulation Strategies in the Treatment of Anorexia Nervosa: A Literature Review.”

Can Transcranial Magnetic Stimulation (TMS) Treat Autism?

No, TMS cannot directly treat autism spectrum disorder (ASD), although it has been studied for managing specific symptoms, such as irritability and repetitive behaviors. Further exploration is needed to establish its long-term efficacy and safety in this population.

A study explored the use of repetitive transcranial magnetic stimulation (rTMS) for treating autism spectrum disorder (ASD) in children aged 6 to 16 years. The participants underwent 10 sessions of rTMS targeting the left dorsolateral prefrontal cortex, but no noteworthy uptick was seen in the Indian Scale for Assessment of Autism (ISAA) scores, either one day or three months after treatment. Mild side effects, such as headaches and neck pain, were reported in some patients, but no major adverse effects were scored.

The study granted that low-frequency rTMS did not majorly make better the ASD symptoms, underpinning the need for further research in this area as advised by Pal et al., 2022 in “The Role of Repetitive Transcranial Magnetic Stimulation in the Treatment of Autism Spectrum Disorder.”

Can Transcranial Magnetic Stimulation (TMS) Treat Aphasia?

Yes, TMS can treat aphasia, having demonstrated promise in improving language recovery in patients with post-stroke aphasia. By stimulating areas adjacent to damaged language centers, TMS empowers neural plasticity. Results vary depending on the duration and severity of aphasia.

A meta-analysis examined the effectiveness of transcranial magnetic stimulation (TMS) in treating post-stroke aphasia and identified optimal treatment parameters. The analysis incorporated 17 studies with 682 patients, parading weighty betterments in language abilities following TMS treatment, with immediate (Hedges’ g = 0.37) and maintenance (Hedges’ g = 0.34) effects.

The study also discovered that arbitrating factors, such as study design and TMS protocol, influenced the effectiveness of treatment. The optimal TMS parameters were realized to be 15 sessions of rTMS lasting 10 minutes, applied to the mirror area within Broca’s area as discussed in “The Therapeutic Effect of Transcranial Magnetic Stimulation on Post-stroke Aphasia and the Optimal Treatment Parameters” by Wang et al. 2024.